Results for “”

Entry Author Date Location
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash 06/26/20 National
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel 06/16/20 Philadelphia
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA 06/11/20 Texas
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic 06/08/20 Boston
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations 05/27/20 New York
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes 05/21/20 Boston
Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases 05/19/20 New York
ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon 05/15/20 New York
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
Page 1 of 90 next page »